Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Deferred Taxes (2020 - 2024)

Revolution Medicines has reported Deferred Taxes over the past 4 years, most recently at $762000.0 for Q4 2024.

  • Quarterly results put Deferred Taxes at $762000.0 for Q4 2024, up 1672.09% from a year ago — trailing twelve months through Dec 2024 was $928000.0 (up 580.83% YoY), and the annual figure for FY2024 was $762000.0, down 80.51%.
  • Deferred Taxes for Q4 2024 was $762000.0 at Revolution Medicines, up from $43000.0 in the prior quarter.
  • Over the last five years, Deferred Taxes for RVMD hit a ceiling of $762000.0 in Q4 2024 and a floor of -$359000.0 in Q4 2020.
  • Median Deferred Taxes over the past 4 years was $83000.0 (2022), compared with a mean of $217166.7.
  • Biggest five-year swings in Deferred Taxes: plummeted 65.04% in 2023 and later skyrocketed 1672.09% in 2024.
  • Revolution Medicines' Deferred Taxes stood at -$359000.0 in 2020, then soared by 134.26% to $123000.0 in 2022, then plummeted by 65.04% to $43000.0 in 2023, then skyrocketed by 1672.09% to $762000.0 in 2024.
  • The last three reported values for Deferred Taxes were $762000.0 (Q4 2024), $43000.0 (Q4 2023), and $123000.0 (Q4 2022) per Business Quant data.